PIM447 is a potent, selective small molecule inhibitor of protein kinase CK1δ, under investigation for its potential role in treating neurodegenerative disorders such as Alzheimer’s disease through the… Read more
PIM447 is a potent, selective small molecule inhibitor of protein kinase CK1δ, under investigation for its potential role in treating neurodegenerative disorders such as Alzheimer’s disease through the modulation of amyloid-beta processing. Pharmaceutical laboratories utilize this compound and its related materials, including hydrochloride salts, as essential reference standards during the drug development process. These high-quality standards are critical for rigorous analytical testing, including impurity profiling and metabolite identification, to ensure accurate quantification and regulatory compliance. Researchers also rely on these compounds for method validation and stable isotope labelled studies, which facilitate precise tracking of the drug’s behavior in complex biological matrices. By providing reliable materials for quality control and quantitative analysis, these products support the ongoing preclinical and clinical research necessary to assess the therapeutic potential of this kinase inhibitor in neurological medicine.